C4 Therapeutics has been launched by the Dana-Farber Cancer Institute with series A funding from investors including Roche, Novartis and Kraft.

Celgene, Eli Lilly and Brace Pharma participated in a series A mezzanine financing round that will help Zymeworks advance its breast cancer drugs into clinical development.

The one-to-one tutoring startup has followed a seed investment by Xueda Edcuation with $9.1m of series A funding from corporate venturing unit Legend Capital.

C4 Therapeutics has been launched by the Dana-Farber Cancer Institute with series A funding from investors including Roche, Novartis and Kraft.

Immuno-oncology company NextCure, which will develop products licensed from Yale School of Medicine, has closed a series A round backed by Pfizer and Eli Lilly.

Taiyu Capital, a corporate venturing unit of TigerMed, is among the investors in a round that increased the concussion response specialist's total funding to $13m.

Fairview Health Services and Ascension have participated in a $17m round as Zipnosis prepares to add support for chronic conditions to its virtual care platform.

Lifesize, Logitech's videoconferencing division, will be spun out with $17.5m in series A capital, with Logitech retaining a 37.5% stake.

The peer-to-peer lending platform has received $46m in its first funding round, which was led by conglomerate HNA's financial services subsidiary.

The Google Ventures-backed app development technology provider has now raised more than $25m in debt and equity since it was founded.